Wells Fargo & Company Tekla Life Sciences Investors Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HQL
# of Institutions
80Shares Held
9.03MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$50.5 Million0.82% of portfolio
-
Morgan Stanley New York, NY490KShares$7.21 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA419KShares$6.17 Million0.53% of portfolio
-
Karpus Management, Inc. Pittsford, NY404KShares$5.95 Million0.18% of portfolio
-
Needham Investment Management LLC New York, NY342KShares$5.03 Million0.42% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...